OBJECTIVES: Endoscopic ultrasound (EUS) evaluation of pancreatic duct compliance after secretin stimulation (sEUS) along with EUS morphologic examination (EUS) and duodenal fluid [HCO3] measurement (endoscopic pancreatic function test, ePFT) in 1 endoscopic session has not been reported as a means of evaluating for chronic pancreatitis (CP). We evaluated the feasibility of the combined examination and compared EUS measurements of pancreatic ductal compliance with duodenal fluid [HCO3] for diagnosing CP. METHODS: The study is a prospective case series of patients with suspected CP who underwent a combined EUS, sEUS, and ePFT examination in 1 endoscopic session. The main outcome measures were the feasibility of performing the combination examination and the correlation between ductal compliance and ePFT. RESULTS: All examinations were completed in 1 endoscopic session, and there were no complications in 35 patients. Although there was a trend toward less change from baseline head and body ductal diameter in patients with CP, only the percent change from baseline in the tail was significant (CP 144.3% vs healthy patients 240.9%, P < 0.01). Regression analysis demonstrated fair correlation between maximum change in ductal diameter and duodenal fluid [HCO3] (r = 0.27). CONCLUSIONS: Combined EUS, sEUS, and ePFTs are feasible and safe, with preliminary results demonstrating a positive correlation between pancreatic ductal compliance and duodenal fluid [HCO3].
OBJECTIVES: Endoscopic ultrasound (EUS) evaluation of pancreatic duct compliance after secretin stimulation (sEUS) along with EUS morphologic examination (EUS) and duodenal fluid [HCO3] measurement (endoscopic pancreatic function test, ePFT) in 1 endoscopic session has not been reported as a means of evaluating for chronic pancreatitis (CP). We evaluated the feasibility of the combined examination and compared EUS measurements of pancreatic ductal compliance with duodenal fluid [HCO3] for diagnosing CP. METHODS: The study is a prospective case series of patients with suspected CP who underwent a combined EUS, sEUS, and ePFT examination in 1 endoscopic session. The main outcome measures were the feasibility of performing the combination examination and the correlation between ductal compliance and ePFT. RESULTS: All examinations were completed in 1 endoscopic session, and there were no complications in 35 patients. Although there was a trend toward less change from baseline head and body ductal diameter in patients with CP, only the percent change from baseline in the tail was significant (CP 144.3% vs healthy patients 240.9%, P < 0.01). Regression analysis demonstrated fair correlation between maximum change in ductal diameter and duodenal fluid [HCO3] (r = 0.27). CONCLUSIONS: Combined EUS, sEUS, and ePFTs are feasible and safe, with preliminary results demonstrating a positive correlation between pancreatic ductal compliance and duodenal fluid [HCO3].
Authors: Marc F Catalano; Anand Sahai; Michael Levy; Joseph Romagnuolo; Maurits Wiersema; William Brugge; Martin Freeman; Kenji Yamao; Marcia Canto; Lyndon V Hernandez Journal: Gastrointest Endosc Date: 2009-02-24 Impact factor: 9.427
Authors: Darwin L Conwell; Gregory Zuccaro; J Brad Morrow; Frederick Van Lente; Cathy O'Laughlin; John J Vargo; John A Dumot Journal: Pancreas Date: 2002-11 Impact factor: 3.327
Authors: Tyler Stevens; Darwin L Conwell; Gregory Zuccaro; Frederick Van Lente; Rocio Lopez; Edward Purich; Seymour Fein Journal: Gastrointest Endosc Date: 2008-03 Impact factor: 9.427
Authors: Darwin L Conwell; Gregory Zuccaro; John J Vargo; Patricia A Trolli; Frederick Vanlente; Nancy Obuchowski; John A Dumot; Cathy O'laughlin Journal: Gastrointest Endosc Date: 2003-01 Impact factor: 9.427
Authors: J Enrique Domínguez-Muñoz; Jose Lariño-Noia; Ana Alvarez-Castro; Laura Nieto; Santiago Lojo; Saul Leal; Daniel de la Iglesia-Garcia; Julio Iglesias-Garcia Journal: United European Gastroenterol J Date: 2020-06-23 Impact factor: 4.623
Authors: John M DeWitt; Mohammad A Al-Haddad; Jeffrey J Easler; Stuart Sherman; James Slaven; Timothy B Gardner Journal: Gastrointest Endosc Date: 2020-06-17 Impact factor: 9.427